haloperidol has been researched along with Asialia in 4 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite the demonstrated efficacy of clozapine in severely refractory schizophrenia, questions remain regarding its efficacy for primary negative symptoms, comparison with a moderate dose of a first-generation antipsychotic, and adverse effects during a longer-term trial." | 9.09 | Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. ( Baker, RW; Borenstein, M; Ganguli, R; Kane, JM; Marder, SR; McMeniman, M; Safferman, A; Schooler, NR; Umbricht, D; Wirshing, DA; Wirshing, WC, 2001) |
| "The purpose of this study was to compare the efficacy of olanzapine with that of chlorpromazine plus benztropine in patients with treatment-resistant schizophrenia." | 9.08 | Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. ( Bartko, JJ; Conley, RR; Gounaris, C; Hegerty, J; Lingle, J; Love, R; Peszke, M; Richardson, C; Tamminga, CA; Zaremba, S, 1998) |
| "Despite the demonstrated efficacy of clozapine in severely refractory schizophrenia, questions remain regarding its efficacy for primary negative symptoms, comparison with a moderate dose of a first-generation antipsychotic, and adverse effects during a longer-term trial." | 5.09 | Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. ( Baker, RW; Borenstein, M; Ganguli, R; Kane, JM; Marder, SR; McMeniman, M; Safferman, A; Schooler, NR; Umbricht, D; Wirshing, DA; Wirshing, WC, 2001) |
| "The purpose of this study was to compare the efficacy of olanzapine with that of chlorpromazine plus benztropine in patients with treatment-resistant schizophrenia." | 5.08 | Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. ( Bartko, JJ; Conley, RR; Gounaris, C; Hegerty, J; Lingle, J; Love, R; Peszke, M; Richardson, C; Tamminga, CA; Zaremba, S, 1998) |
| "Polydipsia was the most prevalent (24, 60." | 1.51 | Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi. ( Chikowe, I; Domingo, M; Kampira, E; Mafuta, C; Mwakaswaya, V; Parveen, S, 2019) |
| "Vomiting was controlled in all patients, with the exception of three patients with upper abdomen obstruction who required nasogastric tube placement." | 1.28 | The management of inoperable gastrointestinal obstruction in terminal cancer patients. ( Caraceni, A; De Conno, F; Messina, L; Ripamonti, C; Spoldi, E; Ventafridda, V, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chikowe, I | 1 |
| Domingo, M | 1 |
| Mwakaswaya, V | 1 |
| Parveen, S | 1 |
| Mafuta, C | 1 |
| Kampira, E | 1 |
| Conley, RR | 1 |
| Tamminga, CA | 1 |
| Bartko, JJ | 1 |
| Richardson, C | 1 |
| Peszke, M | 1 |
| Lingle, J | 1 |
| Hegerty, J | 1 |
| Love, R | 1 |
| Gounaris, C | 1 |
| Zaremba, S | 1 |
| Kane, JM | 1 |
| Marder, SR | 1 |
| Schooler, NR | 1 |
| Wirshing, WC | 1 |
| Umbricht, D | 1 |
| Baker, RW | 1 |
| Wirshing, DA | 1 |
| Safferman, A | 1 |
| Ganguli, R | 1 |
| McMeniman, M | 1 |
| Borenstein, M | 1 |
| Ventafridda, V | 1 |
| Ripamonti, C | 1 |
| Caraceni, A | 1 |
| Spoldi, E | 1 |
| Messina, L | 1 |
| De Conno, F | 1 |
2 trials available for haloperidol and Asialia
| Article | Year |
|---|---|
Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
Topics: Adult; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; | 1998 |
Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
Topics: Adult; Anorexia; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Dizziness; Dose-Re | 2001 |
2 other studies available for haloperidol and Asialia
| Article | Year |
|---|---|
Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Cross-Sectional Studies; Erectile Dysfuncti | 2019 |
The management of inoperable gastrointestinal obstruction in terminal cancer patients.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Butylscopolammonium Bromide; Drug Administratio | 1990 |